Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stepan (SCL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Stepan (SCL) over the last 16 years, with Q3 2025 value amounting to $118.5 million.

  • Stepan's Cash & Equivalents fell 1951.59% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.5 million, marking a year-over-year decrease of 1951.59%. This contributed to the annual value of $99.7 million for FY2024, which is 2323.01% down from last year.
  • According to the latest figures from Q3 2025, Stepan's Cash & Equivalents is $118.5 million, which was down 1951.59% from $88.9 million recorded in Q2 2025.
  • In the past 5 years, Stepan's Cash & Equivalents registered a high of $236.0 million during Q1 2022, and its lowest value of $88.9 million during Q2 2025.
  • For the 5-year period, Stepan's Cash & Equivalents averaged around $137.9 million, with its median value being $127.1 million (2021).
  • In the last 5 years, Stepan's Cash & Equivalents tumbled by 6608.55% in 2021 and then skyrocketed by 5739.45% in 2022.
  • Over the past 5 years, Stepan's Cash & Equivalents (Quarter) stood at $159.2 million in 2021, then grew by 9.15% to $173.8 million in 2022, then fell by 25.28% to $129.8 million in 2023, then fell by 23.23% to $99.7 million in 2024, then grew by 18.94% to $118.5 million in 2025.
  • Its Cash & Equivalents stands at $118.5 million for Q3 2025, versus $88.9 million for Q2 2025 and $107.5 million for Q1 2025.